Redhill Biopharma

$9.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-3.52%) As of 4:34 PM UTC today

Why Robinhood?

You can buy or sell RDHL and other stocks, options, and ETFs commission-free!

About RDHL

Redhill Biopharma Ltd. American Depositary Shares, also called Redhill Biopharma, is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company’s subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel. The listed name for RDHL is Redhill Biopharma Ltd. American Depositary Shares.

CEO

Dror Ben-Asher

Employees

—

Headquarters

Tel Aviv, Tel Aviv

Founded

2009

Market Cap

373.39M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

623.83K

High Today

$10.20

Low Today

$9.31

Open Price

$10.02

Volume

131.53K

52 Week High

$11.52

52 Week Low

$3.26

RDHL Earnings

-$0.38

-$0.24

-$0.11

$0.03

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 12, Pre-Market